Author

Nitin Telang

Director, Cancer Prevention Research Program, Palindrome Liaisons Consultants - Cited by 7,016 - Cancer Stem Cell Biology - Carcinogenesis - Cancer Prevention - Lead Compound Efficacy

Biography

Nitin Telang is from Palindrome Liaisons Consultants, Cancer Prevention Research Program, Montvale, New Jersey, USA and has research interest in endocrinology, hormone, medical science, bio science , Carcinogenesis, clinical science and Cancer Stem Cell Biology
Title
Cited by
Year
Lycium Barbarum Inhibits Growth of Estrogen Receptor Positive Human Breast Cancer Cells by Favorably Altering Estradiol Metabolism
G Li, DW Sepkovic, HL Bradlow, NT Telang, GYC WongNutrition and cancer 61 (3), 408-414, 2009200
57
2009
Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor‑positive clinical breast cancer
NT Telang, G Li, DW Sepkovic, HL Bradlow, GYC WongMolecular medicine reports 5 (1), 22-28, 2012201
49
2012
Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellandae tree
B Mukherjee, N Telang, GYC WongInternational journal of molecular medicine 24 (2), 253-260, 2009200
38
2009
Comparative efficacy of extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cells
N Telang, G Li, D Sepkovic, HL Bradlow, GYC WongNutrition and cancer 66 (2), 278-4, 2014201
28
2014
Growth inhibitory efficacy of Cornus officinalis in a cell culture model for triple‑negative breast cancer
NT Telang, HB Nair, GYC WongOncology letters 17 (6), 5261-5266, 2019201
23
2019
Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer
N TelangOncology Letters 10 (6), 3840-3846, 2015201
19
2015
The nutritional herb Epimedium grandiflorum inhibits the growth in a model for the Luminal A molecular subtype of breast cancer
NT Telang, G Li, M Katdare, DW Sepkovic, HL Bradlow, GYC WongOncology Letters 13 (4), 2477-2482, 2017201
18
2017
Inhibitory effects of Chinese nutritional herbs in isogenic breast carcinoma cells with modulated estrogen receptor function
N Telang, G Li, M Katdare, D Sepkovic, L Bradlow, G WongOncology Letters 12 (5), 3949-3957, 2016201
17
2016
Anti‑proliferative and pro‑apoptotic effects of rosemary and constituent terpenoids in a model for the HER‑2‑enriched molecular subtype of clinical breast cancer
N TelangOncology Letters 16 (4), 5489-5497, 2018201
14
2018
Preclinical in vitro models from genetically engineered mice for breast and colon cancer
N Telang, M KatdareOncology reports 25 (5), 115-1201, 2011201
9
2011
Drug-resistant stem cells: Novel approach for colon cancer therapy
N TelangInternational Journal of Molecular Sciences 23 (5), 251, 2022202
9
2022
Growth inhibitory efficacy and anti‑aromatase activity of Tabebuia avellanedae in a model for post‑menopausal Luminal A breast cancer
N Telang, HB Nair, GYC WongBiomedical reports 11 (5), 222-229, 2019201
8
2019
Efficacy of Dipsacus asperoides (DA) in a model for triple negative breast cancer
N Telang, HB Nair, GYC WongCancer Res 77 (4 Suppl), 4-13, 2017201
8
2017
Targeting drug resistant stem cells in a human epidermal growth factor receptor‑2‑enriched breast cancer model
N TelangWorld Academy of Sciences Journal 1 (2), 86-91, 2019201
7
2019
Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer
HL Bradlow, DW Sepkovic, N Telang, R Tiwariin vivo 25 (4), 585-588, 2011201
7
2011
Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer
N TelangBiomedical Reports (3), 199-204, 20120
7
2017
Epithelial cell culture models for the prevention and therapy of clinical breast cancer
N Telang, M KatdareOncology Letters 3 (4), 744-750, 2012201
6
2012
Natural phytochemicals as testable therapeutic alternatives for HER‑2‑enriched breast cancer
N TelangWorld Academy of Sciences Journal 2 (5), 1-1, 2020202
6
2020
The application of organ culture to the study of colon carcinogenesis
B Reiss, N Telang, GM WilliamsExperimental colon carcinogenesis, 83-94, 2019201
6
2019
Anti‑inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer
N TelangOncology Letters 15 (1), 42-48, 2018201
6
2018

Referred From: https://scholar.google.com/citations?user=gFxgezYAAAAJ&hl=en

Cited by
Citations 7016
h-index 36
i10-index 73
Open Access Journals